Focal Cortical Dysplasia

Status: draft · Last updated 2026-11-03 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Most common surgical lesion in children with drug-resistant focal epilepsy .
  • ILAE classification:
    • Type I is dyslamination only (Ia radial, Ib tangential, Ic both).
    • Type II adds dysmorphic neurons (IIa), plus balloon cells in IIb.
    • Type III accompanies another lesion (IIIa–d).
    • The 2022 update adds mMCD, MOGHE and "no definite FCD", and recommends an integrated, multi-layered diagnosis .
  • Genetics:
    • Type II and hemimegalencephaly are mosaic mTORopathies: somatic MTOR, AKT3, PIK3CA or RHEB, or two-hit DEPDC5, NPRL2 or TSC1/2.
    • Type I, mMCD and MOGHE are linked to somatic SLC35A2 instead .
  • Imaging: look for thickening, gray–white blurring, FLAIR signal and the transmantle sign (type IIb) .
    • Bottom-of-sulcus dysplasia is often missed at first. Use 3T, FDG-PET (hypometabolic in 99%) and postprocessing .
  • Surgery: complete resection matters most. About 70% achieve a favorable outcome. The transmantle sign and BOSD predict an excellent outcome .

Landmark papers

  • Blümcke et al., N Engl J Med 2017: European series of 9,523 epilepsy surgery resections. Malformations of cortical development were 19.8% of cases, FCD was the most common type, and 52.7% of FCD cases were in children .
  • ILAE FCD classification update (Najm et al., Epilepsia 2022): consensus classification that adds mMCD, MOGHE and "no definite FCD" and recommends an integrated, multi-layered diagnosis .

Focal cortical dysplasia (FCD) is a localized malformation of cortical development. It is the most common lesion in children having epilepsy surgery: in a European series of 9,523 resections, malformations of cortical development made up 19.8% of cases, FCD was the most common type, and 52.7% of the FCD cases were in children . This topic covers the ILAE classification, the genetics and the imaging features.

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:fcd:2fdeb7cf067f4226© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Coronal section of frontal cortex: normal gyri with a sharp gray-white junction beside a bottom-of-sulcus focal cortical dysplasia with thickened cortex, a blurred gray-white junction and a transmantle band tapering to the lateral ventricle; insets show dysmorphic neurons (type IIa) and balloon cells (type IIb)CORONAL SECTION, FRONTAL CORTEXsuperior ↑type IIadysmorphic neuronstype IIbdysmorphic neurons+ balloon cellshistology (Nissl/H&E style)thickened cortexat the bottomof a sulcusblurred gray–white junctiontransmantlebandlateralventriclecortex(gray matter)sharp gray–whitejunction (normal)white matter
Coronal section of a frontal gyrus. Left, normal cortex with a sharp gray–white junction. Right, FCD type II at the bottom of a sulcus: thickened cortex, a blurred gray–white junction and a funnel-shaped transmantle band tapering toward the lateral ventricle. Insets show the histology of type IIa (dysmorphic neurons) and type IIb (dysmorphic neurons with balloon cells). Not to scale.

ILAE classification

Genetics: a brief update

Imaging features

Why it matters surgically

Related topics

References

  1. Blumcke I, Spreafico R, Haaker G, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med 2017;377(17):1648–1656. doi:10.1056/NEJMoa1703784. PMID 29069555. verified
  2. Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52(1):158–174. doi:10.1111/j.1528-1167.2010.02777.x. PMID 21219302. verified
  3. Najm I, Lal D, Alonso Vanegas M, et al. The ILAE consensus classification of focal cortical dysplasia: an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia 2022;63(8):1899–1919. doi:10.1111/epi.17301. PMID 35706131. verified
  4. Lim JS, Kim WI, Kang HC, et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 2015;21(4):395–400. doi:10.1038/nm.3824. PMID 25799227. verified
  5. D'Gama AM, Woodworth MB, Hossain AA, et al. Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias. Cell Rep 2017;21(13):3754–3766. doi:10.1016/j.celrep.2017.11.106. PMID 29281825. verified
  6. Baldassari S, Ribierre T, Marsan E, et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol 2019;138(6):885–900. doi:10.1007/s00401-019-02061-5. PMID 31444548. verified
  7. Ribierre T, Deleuze C, Bacq A, et al. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J Clin Invest 2018;128(6):2452–2458. doi:10.1172/JCI99384. PMID 29708508. verified
  8. Bonduelle T, Hartlieb T, Baldassari S, et al. Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). Acta Neuropathol Commun 2021;9(1):3. doi:10.1186/s40478-020-01085-3. PMID 33407896. verified
  9. Barkovich AJ, Kuzniecky RI, Bollen AW, et al. Focal transmantle dysplasia: a specific malformation of cortical development. Neurology 1997;49(4):1148–1152. doi:10.1212/wnl.49.4.1148. PMID 9339707. verified
  10. Colombo N, Tassi L, Deleo F, et al. Focal cortical dysplasia type IIa and IIb: MRI aspects in 118 cases proven by histopathology. Neuroradiology 2012;54(10):1065–1077. doi:10.1007/s00234-012-1049-1. PMID 22695739. verified
  11. Hofman PA, Fitt GJ, Harvey AS, et al. Bottom-of-sulcus dysplasia: imaging features. AJR Am J Roentgenol 2011;196(4):881–885. doi:10.2214/AJR.10.4423. PMID 21427340. verified
  12. Macdonald-Laurs E, Warren AEL, Francis P, et al. The clinical, imaging, pathological and genetic landscape of bottom-of-sulcus dysplasia. Brain 2024;147(4):1264–1277. doi:10.1093/brain/awad379. PMID 37939785. verified
  13. Wang DD, Deans AE, Barkovich AJ, et al. Transmantle sign in focal cortical dysplasia: a unique radiological entity with excellent prognosis for seizure control. J Neurosurg 2013;118(2):337–344. doi:10.3171/2012.10.JNS12119. PMID 23216463. verified
  14. Hartlieb T, Winkler P, Coras R, et al. Age-related MR characteristics in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE). Epilepsy Behav 2019;91:68–74. doi:10.1016/j.yebeh.2018.07.009. PMID 30061008. verified
  15. Bernasconi A, Cendes F, Theodore WH, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia 2019;60(6):1054–1068. doi:10.1111/epi.15612. PMID 31135062. verified
  16. Wagner J, Weber B, Urbach H, et al. Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain 2011;134(Pt 10):2844–2854. doi:10.1093/brain/awr204. PMID 21893591. verified
  17. Willard A, Antonic-Baker A, Chen Z, et al. Seizure outcome after surgery for MRI-diagnosed focal cortical dysplasia: a systematic review and meta-analysis. Neurology 2022;98(3):e236–e248. doi:10.1212/WNL.0000000000013066. PMID 34893558. verified
  18. Lamberink HJ, Otte WM, Blümcke I, et al. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol 2020;19(9):748–757. doi:10.1016/S1474-4422(20)30220-930220-9). PMID 32822635. verified

Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every number cited was checked against the PubMed abstract. The 2022 classification table (including the type Ic definition), the immunohistochemistry panel, the FCD type I imaging findings and the "almost one-third MRI-negative" statement were checked against the open-access full text of reference 3 (PMC9545778). Type III subtypes and the type I/II definitions come from the abstract of reference 2. The surgical section is a brief summary, not a full review of surgical technique. The figure is an original illustration.